| Kelly K Malueg, OD | |
|
1519 Alaskan Way S, Base Seattle Medical, Seattle, WA 98134-1102 | |
| (206) 217-6432 | |
| (206) 217-6636 |
| Full Name | Kelly K Malueg |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 1519 Alaskan Way S, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003993601 | NPI | - | NPPES |
| 2016582 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3054 (Washington) | Primary |
| 152W00000X | Optometrist | 2448 (Oregon) | Secondary |
| 152W00000X | Optometrist | 858 (Idaho) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly K Malueg, OD 1519 Alaskan Way S, Base Seattle Medical, Seattle, WA 98134-1102 Ph: (206) 217-6432 | Kelly K Malueg, OD 1519 Alaskan Way S, Base Seattle Medical, Seattle, WA 98134-1102 Ph: (206) 217-6432 |
News Archive
Cumberland Pharmaceuticals Inc. today announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease (AERD).
Researchers in the Academic Center for Dentistry Amsterdam have created a unique way of identifying patients at risk of osteoporosis by using ordinary dental x-rays. Professor Paul F. van der Stelt and his team developed the largely automated approach to detecting the disease during a three-year, EU-funded collaboration with the Universities of Manchester, Athens, Leuven, and Malmo.
GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).
Cornell biomedical engineers have discovered natural triggers that could reduce the chance of life-threatening, congenital heart defects among newborn infants. Those triggers can override developmental, biological miscues, leading to proper embryonic heart and valve formation.
A 2-month-old infant diagnosed with COVID-19 experienced reversible myocardial injury and heart failure, similar to COVID-19 related heart issues seen in adults, according to a case published in JACC: Case Reports.
› Verified 8 days ago
Isaac H Varon Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6331 Hampton Rd S, Seattle, WA 98118 Phone: 206-725-2748 | |
Westlake Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 400 Pine St Ste 30, Seattle, WA 98101 Phone: 206-624-4898 | |
Dr. Zhi Neng Feng, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 4720 42nd Ave Sw, Seattle, WA 98116 Phone: 206-588-1037 | |
Stephen D Nevett, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 401 Ne Northgate Way Spc 1101, Seattle, WA 98125 Phone: 206-364-2273 Fax: 206-364-2576 | |
Dr. Diana Chau, OD Optometrist Medicare: Medicare Enrolled Practice Location: 9800 4th Ave Ne, Seattle, WA 98115 Phone: 206-302-1200 | |
Cannon Eyecare (at Pike Place's Market Optical) Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1906 Pike Place, Suite 8-b, At Market Optical, Seattle, WA 98101 Phone: 206-448-7739 Fax: 206-448-4924 |